Pro-Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter 2008 Financial Results
NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTC: PRWP.OB), a developer of carbohydrate-based targeted therapeutic compounds to treat cancer and fibrosis, today reported its full year and fourth quarter financial results, for the period ended December 31, 2008.